Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation

Table 2 Recipient demographics

Characteristic		n = 99
Recipient
Age/yr	Median (range)	59 (18-72)
Gender/male	n (%)	61 (62)
MELD at transplant	Median (range)	21 (6-38)
Etiology
EtOH	n (%)	25 (26)
NASH	n (%)	23 (23)
HCC	n (%)	18 (18)
HCV	n (%)	9 (9)
Other	n (%)	24 (24)
Peak AST (Day 1-7)/(IU/L)	Median (range)	631 (144-13645)
Peak ALT (Day 1-7)/(IU/L)	Median (range)	506 (87-5002)
INR (Day 7)	Median (range)	1.1 (0.9-2.5)
Bilirubin (Day 7)/(mg/dL)	Median (range)	1.9 (0.5-16.8)

MELD: Model for end-stage liver disease; EtOH: Alcoholic hepatitis; NASH: Nonalcoholic steatohepatitis; HCC: Hepatocellular carcinoma; HCV: Hepatitis C virus; AST: Aspartate transaminase; ALT: Alanine aminotransferase; INR: International normalized ratio.